Bioactive Components of Houttuynia cordata Thunb and Their Potential Mechanisms Against COVID-19 Using Network Pharmacology and Molecular Docking …

H Yuan, L Liu, J Zhou, T Zhang, JW Daily… - Journal of medicinal …, 2022 - liebertpub.com
We investigated the molecular mechanism by which Houttuynia cordata Thunb (HCT) may
intervene in coronavirus disease 2019 (COVID-19) and COVID-19-induced cytokine storms …

Network pharmacology and molecular docking analysis on mechanisms of Tibetan Hongjingtian (Rhodiola crenulata) in the treatment of COVID-19

L Wang, Y Wang, W Yang, X He… - Journal of medical …, 2021 - microbiologyresearch.org
Introduction. Coronavirus disease 2019 (COVID-19) is a highly contagious disease and
ravages the world. Hypothesis/Gap Statement. We proposed that R. crenulata might have …

[HTML][HTML] Potential compound from herbal food of Rhizoma Polygonati for treatment of COVID-19 analyzed by network pharmacology: Viral and cancer signaling …

C Mu, Y Sheng, Q Wang, A Amin, X Li, Y Xie - Journal of Functional Foods, 2021 - Elsevier
Abstract Rhizoma Polygonati (huangjing in Chinese, 黄精) is a medicine food homology
herb used as a component of traditional Chinese medicine treating COVID-19 in the current …

[HTML][HTML] Network pharmacology and molecular docking-based investigations of Kochiae Fructus's active phytomolecules, molecular targets, and pathways in treating …

SA Khan, TKW Lee - Frontiers in microbiology, 2022 - frontiersin.org
COVID-19 disease is caused by SARS-CoV-2. Hyper-inflammation mediated by
proinflammatory cytokines is humans' primary etiology of SARS-CoV-2 infection. Kochiae …

Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and …

J Wang, W Ge, X Peng, L Yuan, S He, X Fu - Molecular Diversity, 2021 - Springer
Traditional Chinese medicine (TCM) has exerted positive effects in controlling the COVID-19
pandemic. HuaShi XuanFei Formula (HSXFF) was developed to treat patients with mild and …

Evidence-based complementary and alternative medicine exploring active components and mechanism of Jinhua Qinggan Granules in treatment of COVID-19 based …

Y Ren, Z Yin, J Dai, Z Yang, B Ye… - Natural Product …, 2020 - journals.sagepub.com
This study aimed at exploring the active components and mechanisms of Jinhua Qinggan
granules (JQG) in the prevention and treatment of coronavirus disease 2019 (COVID-19) …

Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC–MS/LC–MS characterization …

SK Das, S Mahanta, B Tanti, H Tag, PK Hui - Molecular Diversity, 2022 - Springer
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) is a massive viral disease outbreak of international concerns. The present …

Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus …

M Ye, G Luo, D Ye, M She, N Sun, YJ Lu, J Zheng - Phytomedicine, 2021 - Elsevier
Abstract Background The Coronavirus disease 2019 pneumonia broke out in 2019 (COVID-
19) and spread rapidly, which causes serious harm to the health of people and a huge …

[HTML][HTML] Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2

RV Chikhale, SK Sinha, P Khanal, NS Gurav… - Phytomedicine Plus, 2021 - Elsevier
Abstract Background Since December 2019, SARS-CoV-2 had been a significant threat
globally, which has accounted for about two million deaths. Several types of research are …

Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology

Y Huang, W Zheng, Y Ni, M Li, J Chen, X Liu, X Tan… - BioData mining, 2020 - Springer
Abstract Background Chinese medicine Toujie Quwen granule (TJQW) has proven to be
effective in the treatment of mild coronavirus disease 2019 (COVID-19) cases by relieving …